The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
SMOChem Deoxynucleotide (dNTP) Mix – CD1010/CD1020
SMOChem ™ deoxynucleotide mixture (dNTP) is an aqueous solution containing...
High Speed Microcentrifuge (D1524R)
Compact benchtop microcentrifuge for laboratories requiring high centrifugation speeds, such...
Bioprep 24 – homogenizer
Operation Manual Automated homogenizer / sample preparation workstation: Homogenize, dilute...
PANAMutyper™ Screening Kit ROS1
For the detection of ROS1 fusion genes in FFPE tissues...